Symmetry Investments LP Cuts Stock Position in Danaher Co. (NYSE:DHR)

Symmetry Investments LP lessened its stake in Danaher Co. (NYSE:DHRGet Rating) by 66.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 6,000 shares of the conglomerate’s stock after selling 11,800 shares during the quarter. Symmetry Investments LP’s holdings in Danaher were worth $1,974,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Maryland Capital Advisors Inc. purchased a new stake in shares of Danaher during the fourth quarter worth about $28,000. Dixon Hughes Goodman Wealth Advisors LLC purchased a new stake in shares of Danaher during the fourth quarter worth about $29,000. D Orazio & Associates Inc. purchased a new stake in shares of Danaher during the third quarter worth about $27,000. Lee Financial Co purchased a new stake in shares of Danaher during the fourth quarter worth about $30,000. Finally, Evolution Advisers Inc. purchased a new stake in shares of Danaher during the fourth quarter worth about $32,000. Institutional investors own 78.42% of the company’s stock.

Shares of DHR stock opened at $249.19 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.68 and a quick ratio of 1.27. The company has a market cap of $181.18 billion, a price-to-earnings ratio of 28.84, a PEG ratio of 2.63 and a beta of 0.84. The stock has a 50 day simple moving average of $272.46 and a 200-day simple moving average of $289.54. Danaher Co. has a 1-year low of $233.71 and a 1-year high of $333.96.

Danaher (NYSE:DHRGet Rating) last announced its earnings results on Thursday, April 21st. The conglomerate reported $2.76 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.11. The business had revenue of $7.69 billion during the quarter, compared to the consensus estimate of $7.53 billion. Danaher had a return on equity of 18.64% and a net margin of 21.32%. The business’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the company posted $2.52 EPS. Analysts anticipate that Danaher Co. will post 10.31 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Friday, June 24th will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 0.40%. The ex-dividend date is Thursday, June 23rd. Danaher’s payout ratio is 11.57%.

A number of equities research analysts recently commented on DHR shares. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a report on Friday, April 22nd. UBS Group decreased their target price on Danaher from $365.00 to $340.00 in a report on Sunday, April 24th. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating and set a $278.00 target price for the company. in a report on Monday, April 25th. William Blair reaffirmed an “outperform” rating on shares of Danaher in a report on Friday, April 22nd. Finally, Wells Fargo & Company downgraded Danaher from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $330.00 to $265.00 in a report on Monday, April 25th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Buy” and a consensus price target of $331.14.

In related news, EVP Joakim Weidemanis sold 6,500 shares of the business’s stock in a transaction that occurred on Monday, April 25th. The stock was sold at an average price of $255.74, for a total transaction of $1,662,310.00. Following the completion of the sale, the executive vice president now directly owns 86,398 shares in the company, valued at $22,095,424.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.20% of the stock is currently owned by insiders.

Danaher Company Profile (Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.